Loading...
Drägerwerk AG & Co. KGaA
DRWKF•PNK
Healthcare
Medical - Devices
$67.28
$0.004(0.006%)
Drägerwerk AG & Co. KGaA (DRWKF) Financial Performance & Income Statement Overview
Review Drägerwerk AG & Co. KGaA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-0.08%
↓ 0.08%
Operating Income Growth
-2.23%
↓ 2.23%
Net Income Growth
12.65%
↑ 12.65%
Operating Cash Flow Growth
-11.79%
↓ 11.79%
Operating Margin
4.63%
↑ 4.63%
Gross Margin
44.87%
↑ 44.87%
Net Profit Margin
3.69%
↑ 3.69%
ROE
8.52%
↑ 8.52%
ROIC
7.38%
↑ 7.38%
Drägerwerk AG & Co. KGaA (DRWKF) Income Statement & Financial Overview
Review Drägerwerk AG & Co. KGaA's (DRWKF) income statement with detailed quarterly and annual figures.
Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
---|---|---|---|---|
Revenue | $1.08B | $774.57M | $784.67M | $735.82M |
Cost of Revenue | $581.84M | $437.62M | $436.79M | $402.18M |
Gross Profit | $493.98M | $336.95M | $347.89M | $333.64M |
Gross Profit Ratio | $0.46 | $0.44 | $0.44 | $0.45 |
R&D Expenses | $82.77M | $85.77M | $83.61M | $80.92M |
SG&A Expenses | $287.15M | $236.42M | $246.91M | $237.24M |
Operating Expenses | $394.69M | $312.94M | $330.51M | $318.16M |
Total Costs & Expenses | $976.52M | $750.56M | $767.30M | $720.35M |
Interest Income | $0.00 | $0.00 | $1.16M | $0.00 |
Interest Expense | $0.00 | $0.00 | $5.10M | $0.00 |
Depreciation & Amortization | $0.00 | $0.00 | $32.53M | $32.85M |
EBITDA | $121.73M | $24.008M | $73.78M | $48.67M |
EBITDA Ratio | $0.11 | $0.03 | $0.09 | $0.07 |
Operating Income | $99.29M | $24.008M | $17.37M | $15.47M |
Operating Income Ratio | $0.09 | $0.03 | $0.02 | $0.02 |
Other Income/Expenses (Net) | $8.02M | -$2.94M | $19.11M | -$4.93M |
Income Before Tax | $107.31M | $21.07M | $36.48M | $10.54M |
Income Before Tax Ratio | $0.10 | $0.03 | $0.05 | $0.01 |
Income Tax Expense | $31.93M | $5.76M | $9.94M | $3.001M |
Net Income | $76.03M | $14.66M | $26.64M | $7.08M |
Net Income Ratio | $0.07 | $0.02 | $0.03 | $0.010 |
EPS | $4.05 | $0.77 | $1.42 | $0.38 |
Diluted EPS | $4.05 | $0.77 | $1.42 | $0.38 |
Weighted Avg Shares Outstanding | $18.76M | $19.04M | $18.76M | $18.76M |
Weighted Avg Shares Outstanding (Diluted) | $18.76M | $19.04M | $18.76M | $18.76M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan